Ophthalmic Drug Dosage Forms: Characterisation and Research Methods

被引:176
作者
Baranowski, Przemyslaw [1 ]
Karolewicz, Bozena [1 ]
Gajda, Maciej [1 ]
Pluta, Janusz [1 ]
机构
[1] Wroclaw Med Univ, Dept Drug Form Technol, PL-50556 Wroclaw, Poland
来源
SCIENTIFIC WORLD JOURNAL | 2014年
关键词
IN-VITRO EVALUATION; SILICONE-HYDROGEL; DELIVERY-SYSTEMS; OCULAR DELIVERY; CONTROLLED-RELEASE; FORMULATION; NANOPARTICLES; PILOCARPINE; INSERTS; EYE;
D O I
10.1155/2014/861904
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This paper describes hitherto developed drug forms for topical ocular administration, that is, eye drops, ointments, in situ gels, inserts, multicompartment drug delivery systems, and ophthalmic drug forms with bioadhesive properties. Heretofore, many studies have demonstrated that new and more complex ophthalmic drug forms exhibit advantage over traditional ones and are able to increase the bioavailability of the active substance by, among others, reducing the susceptibility of drug forms to defense mechanisms of the human eye, extending contact time of drug with the cornea, increasing the penetration through the complex anatomical structure of the eye, and providing controlled release of drugs into the eye tissues, which allows reducing the drug application frequency. The rest of the paper describes recommended in vitro and in vivo studies to be performed for various ophthalmic drugs forms in order to assess whether the form is acceptable from the perspective of desired properties and patient's compliance.
引用
收藏
页数:14
相关论文
共 86 条
[1]   Quantitative in vitro comparison of fluorescein delivery to the eye via impregnated paper strip and volumetric techniques [J].
Abdul-Fattah, AM ;
Bhargava, HN ;
Korb, DR ;
Glonek, T ;
Finnemore, VM ;
Greiner, JV .
OPTOMETRY AND VISION SCIENCE, 2002, 79 (07) :435-438
[2]   Biodegradable Ocular Inserts for Sustained Delivery of Brimonidine Tartarate: Preparation and In Vitro/In Vivo Evaluation [J].
Aburahma, Mona Hassan ;
Mahmoud, Azza Ahmed .
AAPS PHARMSCITECH, 2011, 12 (04) :1335-1347
[3]  
[Anonymous], 2012, US PHARM 35, V35
[4]  
[Anonymous], 2013, INT PHARMACOPOEIA
[5]  
[Anonymous], 2008, POL PHARM 1, V8
[6]  
Attia M.A., 2011, INT J PHARMTECH RES, V3, P1750
[7]   PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation [J].
Averineni, Ranjith K. ;
Shavi, Gopal V. ;
Gurram, Aravind K. ;
Deshpande, Praful B. ;
Arumugam, Karthik ;
Maliyakkal, Naseer ;
Meka, Sreenivasa R. ;
Nayanabhirama, Udupa .
BULLETIN OF MATERIALS SCIENCE, 2012, 35 (03) :319-326
[8]  
Bartlett J.D., 2008, CLIN OCULAR PHARM, V5th
[9]   Uptake and Release of Dexamethasone Phosphate From Silicone Hydrogel and Group I, II, and IV Hydrogel Contact Lenses [J].
Boone, Adrienne ;
Hui, Alex ;
Jones, Lyndon .
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2009, 35 (05) :260-267
[10]   Ocular drug delivery: a clue from nanotechnology [J].
Bucolo, Claudio ;
Drago, Filippo ;
Salomone, Salvatore .
FRONTIERS IN PHARMACOLOGY, 2012, 3